- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01418261
SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension
April 24, 2017 updated by: Medtronic Vascular
Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with uncontrolled hypertension.
Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF)energy through the luminal surface of the renal artery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with uncontrolled hypertension.
Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF)energy through the luminal surface of the renal artery.
Study Type
Interventional
Enrollment (Actual)
535
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
Birmingham, Alabama, United States, 35211
- Cardiology, PC
-
-
California
-
La Jolla, California, United States, 92037
- Scripps Clinic/Scripps Green Hospital
-
Los Angeles, California, United States, 90048
- Cedars Sinai Medical Center
-
Los Angeles, California, United States, 90027
- Kaiser Permanente - Los Angeles Medical Center
-
Orange, California, United States, 92868
- St. Joseph Hospital
-
San Diego, California, United States, 92123
- San Diego Cardiac Center
-
Stanford, California, United States, 94305
- Stanford University
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Hospital
-
-
District of Columbia
-
Washington, D.C., District of Columbia, United States, 20060
- Howard University Hospital
-
Washington, D.C., District of Columbia, United States, 20010
- Medstar Washington Hospital Center
-
-
Florida
-
Gainesville, Florida, United States, 32610
- Shands / University of Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic
-
Miami, Florida, United States, 33136
- University of Miami
-
Miami, Florida, United States, 33176
- Baptist Cardiac &Vascular Institute, Baptist Health Systems
-
Tampa, Florida, United States, 33606
- Tampa General Hospital
-
-
Georgia
-
Atlanta, Georgia, United States, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, United States, 30309
- Piedmont Heart Institute
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
Oakbrook Terrace, Illinois, United States, 60181
- Midwest Heart Foundation
-
Springfield, Illinois, United States, 62701
- Prairie Heart Institute
-
-
Iowa
-
Des Moines, Iowa, United States, 50266
- Iowa Heart Center Research
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536
- University of Kentucky
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70121
- Ochsner Medical Center
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland, Baltimore
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02132
- VA Boston Healthcare System
-
Burlington, Massachusetts, United States, 01805
- Lahey Clinic
-
Worcester, Massachusetts, United States, 01655
- UMass Memorial Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
Detroit, Michigan, United States, 48201
- Harper University Hospital - Detroit Medical Center
-
Pontiac, Michigan, United States, 48341
- St Joseph Mercy Oakland Hospital
-
Southfield, Michigan, United States, 48075
- Providence Hospital
-
Ypsilanti, Michigan, United States, 48197
- Michigan Heart, St. Joseph Mercy Health System
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Abbott Northwestern/Minneapolis Heart Institute Foundation
-
Rochester, Minnesota, United States, 55905
- Saint Mary's Mayo Clinic
-
-
Mississippi
-
Hattiesburg, Mississippi, United States, 39401
- Hattiesburg Clinic, P.A
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- Saint Luke's Hospital of Kansas City/Mid America Heart Institute
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
New Jersey
-
Browns Mills, New Jersey, United States, 08015
- Deborah Heart & Lung Center
-
Morristown, New Jersey, United States, 07962
- Morristown Medical Center
-
Neptune City, New Jersey, United States, 07753
- Jersey Shore University Medical Center
-
-
New York
-
Brooklyn, New York, United States, 11203
- SUNY Downstate Medical Center
-
New York, New York, United States, 10032
- Columbia University Medical Center
-
New York, New York, United States, 10021
- Weill Cornell Medical College
-
New York, New York, United States, 10015
- New York University Medical Center
-
New York, New York, United States, 10029
- Mount Sinai Medical Center-Manhattan
-
Roslyn, New York, United States, 11576
- St. Francis Hospital
-
Stony Brook, New York, United States, 11794
- Stony Brook University Hospital and Medical Center
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina Heart and Vascular
-
Charlotte, North Carolina, United States, 28203
- Carolinas Healthcare (SHVI)-Clinical Research
-
Durham, North Carolina, United States, 27710
- Duke University Health System
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Health
-
-
Ohio
-
Cincinnati, Ohio, United States, 45219
- The Lindner Center for Research & Education at The Christ Hospital
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, United States, 44109
- The MetroHealth System
-
Cleveland, Ohio, United States, 44106
- University Hospitals Case Medical Center
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
Columbus, Ohio, United States, 43214-3907
- OhioHealth Research Institute
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Lancaster, Pennsylvania, United States, 17604
- Lancaster General Hospital
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University Hospitals, Inc
-
Philadelphia, Pennsylvania, United States, 19130
- University of Pennsylvania Health System
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC
-
Wynnewood, Pennsylvania, United States, 19096
- Lankenau Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Vascular Disease Research Center at Rhode Island Hospital
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Tennessee
-
Memphis, Tennessee, United States, 38138
- Stern Cardiovascular Foundation, Inc.
-
Nashville, Tennessee, United States, 37232-7235
- Vanderbilt Medical Center
-
-
Texas
-
Austin, Texas, United States, 78756
- Austin Heart PLLC / Heart Hospital of Austin
-
Dallas, Texas, United States, 75216
- VA North Texas Health Care System
-
Dallas, Texas, United States, 75226
- Soltero Cardiovascular Research Center - Baylor Jack and Jane Hamilton Heart & Vascular Hospital
-
Houston, Texas, United States, 77030
- The Methodist Hospital
-
Plano, Texas, United States, 75093
- The Heart Hospital Baylor Plano
-
-
Vermont
-
Burlington, Vermont, United States, 05401
- Fletcher Allen Health Care
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53215
- Aurora St. Luke's Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Individual is ≥ 18 and ≤ 80 years old at time of randomization.
- Individual is receiving a stable medication regimen including full tolerated doses of 3 or more anti-hypertensive medications of different classes, of which one must be a diuretic (with no changes for a minimum of 2 weeks prior to screening) that is expected to be maintained without changes for at least 6 months.
- Individual has an office systolic blood pressure (SBP) of ≥ 160 mmHg based on an average of 3 blood pressure readings measured at both an initial screening visit and a confirmatory screening visit
Exclusion Criteria:
- Individual has an estimated glomerular filtration rate (eGFR) of < 45 mL/min/1.73 m2
- Individual has an Ambulatory Blood Pressure Monitoring (ABPM) 24 hour average SBP < 135 mmHg
- Individual has type 1 diabetes mellitus
- Individual requires chronic oxygen support or mechanical ventilation (e.g., tracheostomy, CPAP, BiPAP) other than nocturnal respiratory support for sleep apnea.
- Individual has primary pulmonary hypertension.
- Individual is pregnant, nursing or planning to be pregnant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Renal Denervation
Subjects are treated with the renal denervation procedure after randomization and maintained baseline anti-hypertensive medications
|
|
|
SHAM_COMPARATOR: Control group
Subjects go through renal angiogram and Subjects maintained baseline anti-hypertensive medications
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Office Systolic Blood Pressure
Time Frame: Baseline to 6 months post-randomization
|
Primary Effectiveness Outcome Measure
|
Baseline to 6 months post-randomization
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in average 24-hour Systolic Blood Pressure by ambulatory blood pressure monitoring
Time Frame: Baseline to 6 months
|
Baseline to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: George Bakris, MD, Professor of Medicine, Hypertension Center Director University of Chicago Medical Center
- Principal Investigator: Deepak L Bhatt, MD, MPH, VA Boston Healthcare System Department of Cardiology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL; SYMPLICITY HTN-3 Steering Committee Investigators. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial. Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18.
- Mahfoud F, Bakris G, Bhatt DL, Esler M, Ewen S, Fahy M, Kandzari D, Kario K, Mancia G, Weber M, Bohm M. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. Eur Heart J. 2017 Jan 7;38(2):93-100. doi: 10.1093/eurheartj/ehw325.
- Pocock SJ, Bakris G, Bhatt DL, Brar S, Fahy M, Gersh BJ. Regression to the Mean in SYMPLICITY HTN-3: Implications for Design and Reporting of Future Trials. J Am Coll Cardiol. 2016 Nov 1;68(18):2016-2025. doi: 10.1016/j.jacc.2016.07.775.
- Kario K, Bhatt DL, Brar S, Cohen SA, Fahy M, Bakris GL. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Hypertension. 2015 Dec;66(6):1130-7. doi: 10.1161/HYPERTENSIONAHA.115.06260. Epub 2015 Oct 5.
- Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. J Am Coll Cardiol. 2015 Apr 7;65(13):1314-1321. doi: 10.1016/j.jacc.2015.01.037.
- Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O'Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015 Jan 21;36(4):219-27. doi: 10.1093/eurheartj/ehu441. Epub 2014 Nov 16.
- Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014 Sep 16;64(11):1071-8. doi: 10.1016/j.jacc.2014.05.012. Epub 2014 May 20.
- Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (ACTUAL)
December 1, 2013
Study Completion (ACTUAL)
February 17, 2017
Study Registration Dates
First Submitted
August 15, 2011
First Submitted That Met QC Criteria
August 16, 2011
First Posted (ESTIMATE)
August 17, 2011
Study Record Updates
Last Update Posted (ACTUAL)
April 26, 2017
Last Update Submitted That Met QC Criteria
April 24, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IP125
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uncontrolled Hypertension
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingUncontrolled Hypertension
-
Colleen J KleinEnrolling by invitationUncontrolled HypertensionUnited States
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingUncontrolled HypertensionChina
-
Heart Center Leipzig - University HospitalActive, not recruitingArterial Hypertension | Uncontrolled HypertensionGermany
-
AstraZenecaCompleted
-
Shanghai Golden Leaf MedTec Co. LtdEuropean Cardiovascular Research CenterWithdrawnUncontrolled HypertensionSwitzerland
-
CVRx, Inc.Suspended
-
Verve Medical, IncClinical Accelerator (CRO); Israeli-Georgian Medical Research Clinic Helsicore and other collaboratorsActive, not recruitingHypertension | Uncontrolled HypertensionGeorgia
-
Abbott Medical DevicesCompletedUncontrolled HypertensionSpain, Belgium, Estonia, Italy, Portugal, United Kingdom
-
Medtronic VascularCompletedUncontrolled HypertensionAustralia, New Zealand
Clinical Trials on Renal denervation (Symplicity Catheter System)
-
Baker Heart and Diabetes InstituteCompletedHypertension | End-stage Renal DiseaseAustralia
-
Baker Heart and Diabetes InstituteTerminated
-
Adolfo FontenlaRecruiting
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Pamela Youde Nethersole Eastern HospitalTerminatedDiabetes Mellitus | Hypertension, Resistant | Renal Denervation TherapyHong Kong
-
Technical University of MunichCompletedHypertension | Chronic Kidney Disease | Renal Transplantation | Sympathetic ActivityGermany
-
Institute of Cardiology, Warsaw, PolandCompletedHypertension | Obstructive Sleep ApneaPoland
-
Singapore General HospitalNational Heart Centre SingaporeNo longer availableHypertension | Chronic Kidney DiseaseSingapore
-
University Hospital, SaarlandWithdrawnChronic Heart Failure | Cardio-Renal SyndromeAustria, Germany, Switzerland, Sweden
-
University Hospital of North NorwayUniversity of Tromso; The Royal Norwegian Ministry of Health; Odd Berg Medical...CompletedHypertension, Resistant to Conventional TherapyNorway